Theo Dhote
Frankfurt Am Main, HE, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
The impact of progressive expansion of elexacaftor-tezacaftor-ivacaftor availability on lung transplant for cystic fibrosis in France.
Journal: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society
Published: January 15, 2026
Cytosolic proliferating cell nuclear antigen (PCNA) orchestrates neutrophil hyperactivation in COVID-19.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: October 21, 2025
Reversal of cylindrical bronchial dilatations in a subset of adults with cystic fibrosis treated with elexacaftor/tezacaftor/ivacaftor.
Journal: The European respiratory journal
Published: May 30, 2023
Normalisation of circulating neutrophil counts after 12 months of elexacaftor-tezacaftor-ivacaftor in patients with advanced cystic fibrosis.
Journal: The European respiratory journal
Published: August 30, 2022
Specific circulating neutrophils subsets are present in clinically stable adults with cystic fibrosis and are further modulated by pulmonary exacerbations.
Journal: Frontiers in immunology
Published: August 05, 2022
Superior mesenteric artery syndrome
Journal: Presse medicale (Paris, France : 1983)
Published: October 27, 2018
Showing 1-8 of 8
Last Updated: 09/26/2026